Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
ADS-TEC Energy answers shareholder questions ahead of Sept. 21 AGM

ADS-TEC Energy answers shareholder questions ahead of Sept. 21 AGM

ReutersReuters2026/09/01 09:13
  • ADS-TEC Energy published proxy Q&A ahead of its Sept. 21, 2026 AGM in Dublin, setting Aug. 27, 2026 as record date.
  • Voting rights set at one vote per ordinary share; 75,185,986 ordinary shares outstanding as of the record date.
  • Quorum requires at least two shareholders holding more than 50% of votes, present in person or by proxy; abstentions count for quorum.
  • Key decision point flagged for Proposal 7: 75% of votes cast needed to allow cash share issues without statutory pre-emption rights.
  • Proposal 6 framed as ordinary-resolution authority to allot up to 15,037,197 shares, about 20% of issued ordinary share capital, for 18 months.
  • Broker discretion applies to Proposals 1, 2, 3, 6, 7; director re-elections are non-routine, risking broker non-votes without instructions.
  • Proxy deadline set for 2 p.m. Dublin time on Sept. 18, 2026; revocations must meet the same cutoff for registered holders.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADS-TEC Energy plc published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Strong demand for cardiac devices drives Medtronic (MDT.US) to exceed Q1 expectations and raise full-year guidance; invests $700 million to expand robotic surgery business.

Medical device manufacturer Medtronic reported better-than-expected results for the first quarter of fiscal year 2027 and raised its full-year guidance, betting on strong demand for its cardiac devices used in complex cardiovascular surgeries.

智通财经2026/09/01 13:06
Strong demand for cardiac devices drives Medtronic (MDT.US) to exceed Q1 expectations and raise full-year guidance; invests $700 million to expand robotic surgery business.